
Istockphoto
Scientists have successfully used a leukemia drug to reverse type 1 diabetes—at least in mice. Researchers at the University of California, San Francisco and Plexxikon, a pharmaceutical research firm, studied two cancer drugs—Gleevec (imatinib) and Sutent (sunitinib)—in non-obese diabetic mice, which were prone to developing diabetes.
Both drugs are tyrosine kinase inhibitors, which interfere with cell communication and growth and are used to fight tumors. Gleevec is prescribed for chronic myelogenous leukemia and Sutent is used to treat advanced kidney cancer and a type of stomach cancer. Read More
No comments:
Post a Comment